EUVIMEDEUVIMED entdecken
Crossref

Repurposing Efavirenz, the HIV Antiretroviral Drug for Chikungunya Virus Infection

Sanketkumar Nehul, Ruchi Rani, Priyanshu Walia, Prasan Kumar Panda, Sharad Singh, Soma Chattopadhyay, Pravindra Kumar, Shailly Tomar iD

ACS Infectious Diseases · 2025

DOI: 10.1021/acsinfecdis.4c00992 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Sanketkumar Nehul und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Bioengineering, Indian Institute of Technology, Roorkee, Uttarakhand 247667, India. Hauptthemen laut MEDLINE: Benzoxazines, Drug Repositioning, Chikungunya virus, Antiviral Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Indian Council of Medical Research, University Grants Commission, Ministry of Education, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzoxazinesDrug RepositioningChikungunya virusAntiviral AgentsChikungunya FeverCyclopropanesAlkynesAnimalsHumansMiceVirus ReplicationCell Line

Stichwörter der Autor:innen

Sindbisantiviralchikungunyaefavirenzin vitroin vivo

Substanzen

efavirenzCyclopropanesAlkynesBenzoxazinesAntiviral Agents

Autor:innen und Institutionen

  • Department of Biosciences and Bioengineering, Indian Institute of Technology, Roorkee, Uttarakhand 247667, India.
  • Department of medicine, All India Institute of Medical Sciences (AIIMS), Rishikesh 249203, India.
  • Institute of Life Sciences (ILS), Bhubaneswar, Odisha 751023, India.
  • KIIT School of Biotechnology, KIIT University, Bhubaneswar, Odisha 751024, India.

ORCID-Profile: Shailly Tomar

Förderung

  • Indian Council of Medical Research
  • University Grants Commission
  • Ministry of Education, India
  • Indian Institute of Technology Roorkee

Zitieren

APA

Nehul, S., Rani, R., Walia, P., Panda, P. K., Singh, S., Chattopadhyay, S., Kumar, P., & Tomar, S. (2025). Repurposing Efavirenz, the HIV Antiretroviral Drug for Chikungunya Virus Infection. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00992

Vancouver

Nehul S, Rani R, Walia P, Panda PK, Singh S, Chattopadhyay S, et al. Repurposing Efavirenz, the HIV Antiretroviral Drug for Chikungunya Virus Infection. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.4c00992

BibTeX
@article{Nehul2025,
  author = {Nehul, Sanketkumar and Rani, Ruchi and Walia, Priyanshu and Panda, Prasan Kumar and Singh, Sharad and Chattopadhyay, Soma and Kumar, Pravindra and Tomar, Shailly},
  title = {Repurposing Efavirenz, the HIV Antiretroviral Drug for Chikungunya Virus Infection},
  journal = {ACS Infectious Diseases},
  year = {2025},
  doi = {10.1021/acsinfecdis.4c00992}
}
Kostenlos starten →